Food & Food Contact Materials
CIRS Group
Chemicals
Cosmetic
Food
Medical Devices
Agrochemicals
CIRS Testing
Carbon Neutrality
Search

Analysis on China Health Food (Dietary Supplement) Registration of 2025

from CIRS by

According to the information released by the Center for Food Evaluation, State Administration for Market Regulation (SAMR), and the Special Food Information Query Platform, it issued a total of 2,130 health food (dietary supplement) registration approvals in 2025. Among them, 200 approvals were for new health food products, including 194 domestic products and six imported products.

China,Health,Food,Registration,Filing,Dietary,Supplement

CIRS conducted a detailed summary of these 200 new products, and analyzed from the following points.

1. The Overall Situation of Health Food Registration Approvals Announced in 2025

Among the 2,130 registration approvals, 200 are new products, accounting for 9.39% of the total; 243 are products for technology transfer, accounting for 11.41% of the total. The other 1,687 registration approvals, not for new products, included renewal registration and change registration.

2. The Number of Approved Products in Different Countries/Regions

Among the 200 approved new products, domestic products are from 25 provinces (municipalities and/or autonomous regions). Beijing ranked first with 46 products, accounting for 23.71% of the total domestic new products. Imported products are from Hong Kong (four products), Indonesia (one product), and Singapore (one product).

Note: If the applicant includes more than one enterprise and comes from different provinces, each province is included in the statistics.

3. Enterprises Obtaining Health Food Registration Certificates

Beijing Jinpingkang Pharmaceutical Technology Co., Ltd. obtained seven new product registration approvals in 2025, taking the top position, followed closely by its parent company, Beijing Century Health Care Pharmaceutical Technology Co., Ltd., which obtained five new product registration approvals.

Of the six imported products, four were from WRIGHT LIFE PHARMACEUTICAL LIMITED, while the remaining two came from PT. HELMIGS PRIMA SEJAHTERA and HSIEHS BIOTECH, respectively. Refer to the table below for details.

Table1. Information for imported products approved in 2025

Product Name

Approval Number

Applicant

Country (region) of Production

Health Function

WRIGHT LIFE NOTOGINSENG AND PANAX QUINQUEFOLIUS CAPSULES

国食健注J20250001

WRIGHT LIFE PHARMACEUTICAL LIMITED

Hong Kong, China

Aids in enhancing immunity

HELMIG'S CURCUMIN TABLET

国食健注J20250002

PT. HELMIGS PRIMA SEJAHTERA

Indonesia

Aids in maintaining healthy blood lipid levels & provides auxiliary protective action against chemical liver damage

WRIGHT LIFE GANODERMA SPORE CAPSULES

国食健注J20250003

WRIGHT LIFE PHARMACEUTICAL LIMITED

Hong Kong, China

Aids in enhancing immunity

WRIGHT LIFE BLUEBERRY LUTEIN CAPSULES

国食健注J20250004

WRIGHT LIFE PHARMACEUTICAL LIMITED

Hong Kong, China

Alleviating visual fatigue

WRIGHT LIFE AGARICUS BLAZEI GANODERMA CAPSULES

国食健注J20250005

WRIGHT LIFE PHARMACEUTICAL LIMITED

Hong Kong, China

Aids in enhancing immunity

GOLDEN LYPRES

国食健注J20250006

HSIEHS BIOTECH

Singapore

Aids in enhancing immunity

4. The Number of Approved Products with Different Dosage Forms

The dosage forms of approved new products (including imported products) includes: capsule, tablet, powder, and oral liquid. Among them, hard capsule products received the largest number of approvals (61), followed by tablet products (40).

5. The Number of Approved Products with Different Health Functions

5.1 Single health function

As shown in Fig.5-1, there are a total of 187 new products (including imported products) approved with a single health function. Among them, products with the health function of “Aids in enhancing immunity” received the largest number of approvals, with 71.

5.2 Two health functions

Except for those new products with a single health function, there are also 13 products approved with two health functions (shown in Fig.5-2).

6. CIRS Comments

1) Fewer in quantity, but higher in quality

The stringent technical review and on-site inspection limit the number of approved new products to only a few hundred each year, thereby ensuring their safety and quality from the source. Unlike the health food filing products, thousands of which are approved each year, the registration products are fostering a “fewer but better” market model. Under this model, enterprises focus on health functions that are more targeted and closely aligned with societal health needs when developing new products. This approach enhances product value and competitiveness, enabling enterprises to command a premium even amid pricing pressure from filing products.

2) Imported products bring new vitality

The six imported products approved in 2025 broke the seven-year silence of "zero approval". This not only serves as a booster for foreign enterprises – signaling that China's health food market remains open to imported products that comply with regulatory requirements, but also serves as a reminder to domestic companies – with new imported products entering the market, competition will intensify, and the key to respond is to explore and strengthen differentiated advantages.

In 2025, GB 17405-1998 Good Manufacturing Practice for Health Food, which has been in force for over two decades, was updated for the first time. The new national standard will take effect on September 2, 2026. It refines requirements about indicator settings and management systems to better protect consumer health, foster industry development, and guide regulatory practice.

Note: There may be a lag in the data release of the Special Food Information Query Platform. The data in this article is only for reference, and the actual situation is subject to the official announcement.

Data Source:

Special Food Information Query Platform of State Administration for Market Regulation (SAMR) and new approval announcements.

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

  

We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Contact Us
+353 1 477 3710 (EU)
+44 20 3239 9430 (UK)
+1 703 520 1420 (USA)
+86 571 8720 6574 (CN)
+82 2 6347 8816 (KR)
+81 070-9365-8022 (JP)